已收盘 07-24 16:00:00 美东时间
0.000
0.00%
(来源:一棵大松树) 携手默沙东深耕TROP2ADC全球布局,具有BIC潜力 芦康沙妥珠单抗(SKB264)是公司自主研发的一款靶向...
08-06 15:27
An update from Triumph Group ( ($TGI) ) is now available. On July 24, 2025, Tri...
07-25 05:28
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250724-1478929/1478929_tgi6.pdf
07-25 05:17
Triumph Group ( ($TGI) ) just unveiled an announcement. On June 30, 2025, Trium...
07-08 04:58
Today, Triumph Group, Inc. (TRIUMPH) (NYSE:TGI) and Divergent Technologies, Inc. (Divergent) announced a partnership to qualify multiple critical manned aircraft components manufactured with the Divergent Adaptive
06-19 19:05
众信博睿承办北京文旅全年会奖推广项目 首站闪耀2025法兰克福IMEX展 深化合作擘画国际交往新蓝图 近日,全球会展行业年度盛会—...
05-27 13:45
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity:维持Verve Therapeutics(VERV)"买入"评级,目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.:维持Verve Ther
04-16 09:45
Physician survey shows high uptake of Neurocrine Biosciences' Crenessity for patients with CAH.
04-15 23:57
J.P. Morgan analyst Seth Seifman upgraded Triumph Group (TGI – Research Report)...
04-15 17:17